Intervention to Improve HIV Care Retention and Antiretroviral Adherence inStigmatized Environments

在污名化环境中改善艾滋病毒护理保留和抗逆转录病毒治疗依从性的干预措施

基本信息

  • 批准号:
    9927034
  • 负责人:
  • 金额:
    $ 62.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-12-16 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

The global scale-up of antiretroviral therapy (ART) is aimed to achieve 90% HIV suppression worldwide. However, even with increased access to ART, many countries are not on track to achieving this goal. Among the factors that impede retention in HIV care, ART adherence and HIV suppression is the social stigmatization of HIV infection. HIV stigmas and behaviors intended to avoid stigma have the adverse consequences of deterring people from seeking care, interfering with clinic attendance, and detracting from taking ART. Interventions to increase HIV care retention and ART adherence have not thus far focused on reducing the adverse effects of stigma in countries where HIV is most prevalent. This application proposes to test a theory-based mobile-phone delivered counseling intervention designed to address HIV-stigma concerns in order to improve HIV treatment retention and adherence in South Africa. The intervention is grounded in Behavioral Self-Regulation Theory and the HIV Stigma Framework and was developed in partnership with South African public health agencies. The intervention approach uses health decision- making and problem-solving skills aimed at resolving social and structural barriers to care, and is delivered by community health worker/lay counselors to increase its potential for scale-up. To test the efficacy of this newly developed and fully pilot tested intervention model, we will conduct a randomized clinical trial designed to tease-out the additive effects of directly addressing stigma concerns by augmenting a Behavioral Self- Regulation Counseling with stigma management components. We will conduct a 3-arm clinical trial in a resource limited township in South Africa that has shown evidence of high-HIV stigma to compare: (a) Behavioral Self-Regulation + Stigma Management Counseling for HIV treatment retention and adherence, vs. (b) Behavioral Self-Regulation Counseling for HIV treatment retention and adherence, vs. (c) Uniform standard of care HIV patient education. The trial will enroll 1200 men and women with unsuppressed HIV and receiving HIV treatment in South Africa’s HIV care system. Participants will be followed for 15-months post-intervention to assess intervention effects on HIV care retention and HIV suppression (primary outcomes) and ART adherence (secondary outcome). Conditional process modeling will determine underlying mechanisms (e.g., self-efficacy, behavioral strategies, internalized stigma, anticipated stigma) that account for intervention effects and how these mechanisms may vary by level of baseline experiences with enacted HIV stigma. The trial will also perform implementation research activities to inform potential scale-up should the intervention be shown efficacious. This newly developed intervention model is designed for use with existing clinical resources in WHO defined systems of differentiated HIV care.
全球扩大抗逆转录病毒疗法(ART)的目标是在全球范围内实现90%的艾滋病毒抑制。 然而,即使增加了抗逆转录病毒治疗的机会,许多国家仍然没有走上实现这一目标的轨道。 在阻碍艾滋病毒护理、抗逆转录病毒疗法坚持和艾滋病毒抑制的因素中, 对艾滋病毒感染者的污名化。艾滋病毒的耻辱感和旨在避免耻辱感的行为 阻止人们寻求护理的后果,干扰诊所出勤, 到目前为止,提高艾滋病毒护理保留率和ART依从性的干预措施尚未得到关注 在艾滋病毒最流行的国家减少耻辱的不利影响。本申请提出 测试一项基于理论的手机咨询干预措施,旨在解决艾滋病毒污名问题, 在南非,艾滋病毒治疗的保留率和坚持率都有所提高。述干预 基于行为自我调节理论和艾滋病毒污名框架, 与南非公共卫生机构合作。干预方法使用健康决策- 制定和解决问题的技能,旨在解决社会和结构性障碍的照顾,并提供 由社区卫生工作者/非专业顾问提供,以增加其扩大规模的潜力。为了测试这个的功效 新开发的并经过充分试点测试的干预模型,我们将进行一项随机临床试验, 通过增强行为自我, 规范咨询与耻辱管理组件。我们将进行一项3组临床试验, 南非资源有限的乡镇,有证据表明艾滋病毒的高耻辱感,以比较:(a) 行为自我调节+污名管理咨询艾滋病毒治疗的保留和坚持, vs. (b)行为自我调节咨询对艾滋病毒治疗的保留和坚持,与(c)统一 艾滋病患者护理标准教育。该试验将招募1200名未受抑制的艾滋病毒感染者 并在南非的艾滋病护理系统接受艾滋病治疗。参与者将被跟踪15个月 干预后评估干预对艾滋病毒护理保留和艾滋病毒抑制的影响(初级 结果)和ART依从性(次要结果)。条件过程建模将确定 基础机制(例如,自我效能、行为策略、内化污名、预期污名 解释干预效果以及这些机制如何因基线经验水平而异 艾滋病的耻辱感。该试验还将进行实施研究活动,以告知潜在的 如果干预措施显示有效,则扩大规模。这种新开发的干预模式是 旨在与世卫组织确定的艾滋病毒差别化护理系统中的现有临床资源一起使用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SETH C KALICHMAN其他文献

SETH C KALICHMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SETH C KALICHMAN', 18)}}的其他基金

DOSE DETERMINATION TRIAL FOR IMPLEMENTING EVIDENCE-BASEDBEHAVIORAL INTERVENTIONS
实施循证行为干预的剂量确定试验
  • 批准号:
    10526406
  • 财政年份:
    2020
  • 资助金额:
    $ 62.41万
  • 项目类别:
DOSE DETERMINATION TRIAL FOR IMPLEMENTING EVIDENCE-BASEDBEHAVIORAL INTERVENTIONS
实施循证行为干预的剂量确定试验
  • 批准号:
    9927041
  • 财政年份:
    2020
  • 资助金额:
    $ 62.41万
  • 项目类别:
DOSE DETERMINATION TRIAL FOR IMPLEMENTING EVIDENCE-BASEDBEHAVIORAL INTERVENTIONS
实施循证行为干预的剂量确定试验
  • 批准号:
    10318539
  • 财政年份:
    2020
  • 资助金额:
    $ 62.41万
  • 项目类别:
DOSE DETERMINATION TRIAL FOR IMPLEMENTING EVIDENCE-BASEDBEHAVIORAL INTERVENTIONS
实施循证行为干预的剂量确定试验
  • 批准号:
    10089484
  • 财政年份:
    2020
  • 资助金额:
    $ 62.41万
  • 项目类别:
Intervention to Improve HIV Care Retention and Antiretroviral Adherence inStigmatized Environments
在污名化环境中改善艾滋病毒护理保留和抗逆转录病毒治疗依从性的干预措施
  • 批准号:
    10533746
  • 财政年份:
    2019
  • 资助金额:
    $ 62.41万
  • 项目类别:
Intervention to Improve HIV Care Retention and Antiretroviral Adherence inStigmatized Environments
在污名化环境中改善艾滋病毒护理保留和抗逆转录病毒治疗依从性的干预措施
  • 批准号:
    10300062
  • 财政年份:
    2019
  • 资助金额:
    $ 62.41万
  • 项目类别:
Comparative Effectiveness Trial for Retention-Adherence-Health
保留-依从-健康的比较有效性试验
  • 批准号:
    8839974
  • 财政年份:
    2014
  • 资助金额:
    $ 62.41万
  • 项目类别:
Comparative Effectiveness Trial for Retention-Adherence-Health
保留-依从-健康的比较有效性试验
  • 批准号:
    9418263
  • 财政年份:
    2014
  • 资助金额:
    $ 62.41万
  • 项目类别:
Comparative Effectiveness Trial for Retention-Adherence-Health
保留-依从-健康的比较有效性试验
  • 批准号:
    9326100
  • 财政年份:
    2014
  • 资助金额:
    $ 62.41万
  • 项目类别:
Comparative Effectiveness Trial for Retention-Adherence-Health
保留-依从-健康的比较有效性试验
  • 批准号:
    8925755
  • 财政年份:
    2014
  • 资助金额:
    $ 62.41万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了